Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Authors
About
Podcasts
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 9, Issue 1
Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Epidemiology and outcomes
Original research
Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus
Online download statistics by month:
Online download statistics by month: August 2022 to October 2023
Abstract
Full
Pdf
Aug 2022
856
864
146
Sep 2022
335
332
63
Oct 2022
165
167
56
Nov 2022
101
101
38
Dec 2022
56
56
25
Jan 2023
78
78
23
Feb 2023
63
63
22
Mar 2023
42
43
18
Apr 2023
26
28
14
May 2023
26
25
18
Jun 2023
37
36
8
Jul 2023
31
31
11
Aug 2023
40
40
18
Sep 2023
24
25
11
Oct 2023
18
18
3
Total
1898
1907
474
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF